人早期酒精相关肝病中十二指肠CD8+组织驻留记忆T细胞凋亡促进肠道屏障功能障碍与微生物易位
研究比较酒精使用障碍(AUD)康复项目患者、非酒精性脂肪性肝病(NAFLD)患者和健康对照,发现合并早期酒精相关肝病(ALD)的AUD患者十二指肠CD8+组织驻留记忆T细胞(TRM)数量减少,其凋亡由溶酶体膜通透化及组织蛋白酶B释放驱动,并与鞘脂代谢改变和微生物易位标志物升高相关,短期戒酒未逆转该细胞死亡。
要点
- 合并早期ALD的AUD患者十二指肠CD8+ TRM细胞数量较对照和NAFLD患者减少。
- TRM凋亡由溶酶体膜通透化及组织蛋白酶B释放至胞质驱动,体外实验证实。
- 十二指肠TRM凋亡与微生物易位标志物升高相关,短期戒酒未逆转TRM死亡。
核心结论
- 十二指肠CD8+ TRM细胞凋亡与溶酶体功能及脂质代谢改变相关,提示AUD发展为早期ALD的患者存在肠道适应性免疫受损。
研究设计与样本
- 研究纳入接受康复项目的酒精使用障碍(AUD)患者,并与非酒精性脂肪性肝病(NAFLD)患者及健康对照比较。
- 通过临床和实验室数据(肝硬度、受控衰减参数、AST、ALT、K18-M65)将AUD患者分为单纯脂肪变性(轻微肝病)组和脂肪性肝炎/纤维化(ALD)组。
- 采用ELISA检测血清微生物易位标志物,靶向LC-MS检测十二指肠和血浆鞘脂水平。
- 通过免疫组化、流式细胞术和FACS分选细胞的RNA测序表征十二指肠活检中的T淋巴细胞,并在体外评估T细胞改变的机制。
主要发现
- 合并ALD的患者十二指肠CD8+ TRM细胞数量较对照或NAFLD患者减少,而轻微肝病患者未见减少。
- TRM转录组分析、体外分析和组织蛋白酶B药理抑制证实,TRM凋亡由溶酶体膜通透化及组织蛋白酶B释放至胞质驱动。
- 脂质代谢改变及十二指肠和血浆鞘脂升高与凋亡相关,二氢神经酰胺剂量依赖性降低TRM活力。
- 十二指肠TRM表型改变、凋亡和转录组改变与微生物易位标志物水平升高相关。
- 短期戒酒未逆转ALD患者的TRM细胞死亡。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intestinal T cells are key in gut barrier function. Their role in early stages of alcohol-associated liver disease (ALD) remain unknown. AIM: To explore the links between intestinal T cells, microbial translocation and ALD METHODS: Patients with alcohol use disorder (AUD) following a rehabilitation programme were compared to subjects with non-alcoholic fatty liver disease (NAFLD) and healthy controls. Clinical and laboratory data (liver stiffness, controlled attenuation parameter, AST, ALT, K18-M65) served to identify AUD patients with isolated steatosis (minimal liver disease) or steatohepatitis/fibrosis (ALD). Serum microbial translocation markers were measured by ELISA, duodenal and plasma levels of sphingolipids by targeted LC-MS. T lymphocytes in duodenal biopsies were characterised by immunohistochemistry, flow cytometry and RNA sequencing on FACS-sorted cells. Mechanisms for T-cell alterations were assessed in vitro. RESULTS: Patients with ALD, but not those with minimal liver disease, showed reduced numbers of duodenal CD8+ T resident memory (TRM) cells compared to controls or patients with NAFLD. TRM transcriptomic analysis, in vitro analyses and pharmacological inhibition of cathepsin B confirmed TRM apoptosis driven by lysosomal membrane permeabilisation and cathepsin B release into the cytosol. Altered lipid metabolism and increased duodenal and plasma sphingolipids correlated with apoptosis. Dihydroceramide dose-dependently reduced viability of TRM. Duodenal TRM phenotypic changes, apoptosis and transcriptomic alterations correlated with increased levels of microbial translocation markers. Short-term abstinence did not reverse TRM cell death in patients with ALD. CONCLUSIONS: Duodenal CD8+ TRM apoptosis related to functional changes in lysosomes and lipid metabolism points to impaired gut adaptive immunity specifically in patients with AUD who developed early ALD.
引用
- Maccioni L, Loriot A, Dewulf J, et al. Duodenal CD8+ T resident memory cell apoptosis contributes to gut barrier dysfunction and microbial translocation in early alcohol-associated liver disease in humans. Aliment Pharmacol Ther. 2022. PMID: 35919965. doi:10.1111/apt.17177
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。